NA
GOSS icon

NewEdge Advisors’s Gossamer Bio GOSS Stock Holding History

NewEdge Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6K Buy
+21,893
New +$6.11K ﹤0.01% 3806
2023
Q1 		– Sell
-145
Closed -$315 – 3718
2022
Q4 		$315 Buy
+145
New +$1.19K ﹤0.01% 3247

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

NewEdge Advisors's GOSS Position: Q2 2026 in Review

NewEdge Advisors opened a new position in Gossamer Bio (GOSS) in Q2 2026: 21,893 shares worth $3.6K. The stake represents ﹤0.01% of the portfolio and ranks #3806 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in GOSS as recently as Q4 2022.

NewEdge Advisors first reported a position in GOSS in Q4 2022 and has held it in 2 quarters since. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • NewEdge Advisors held 21,893 shares of Gossamer Bio worth $3.6K as of Q2 2026.
  • Gossamer Bio was a new NewEdge Advisors position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3806 holding.
  • NewEdge Advisors first reported a position in Gossamer Bio in Q4 2022 and has held it in 2 quarters since.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.